nodes	percent_of_prediction	percent_of_DWPC	metapath
Dimenhydrinate—Neuropathy peripheral—Altretamine—ovarian cancer	0.0263	0.0263	CcSEcCtD
Dimenhydrinate—Neuritis—Chlorambucil—ovarian cancer	0.0228	0.0228	CcSEcCtD
Dimenhydrinate—Vertigo—Altretamine—ovarian cancer	0.0188	0.0188	CcSEcCtD
Dimenhydrinate—Convulsion—Altretamine—ovarian cancer	0.0182	0.0182	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Altretamine—ovarian cancer	0.0168	0.0168	CcSEcCtD
Dimenhydrinate—Anorexia—Altretamine—ovarian cancer	0.0163	0.0163	CcSEcCtD
Dimenhydrinate—Chest tightness—Docetaxel—ovarian cancer	0.0158	0.0158	CcSEcCtD
Dimenhydrinate—Decreased appetite—Altretamine—ovarian cancer	0.0149	0.0149	CcSEcCtD
Dimenhydrinate—Fatigue—Altretamine—ovarian cancer	0.0148	0.0148	CcSEcCtD
Dimenhydrinate—Haemolytic anaemia—Chlorambucil—ovarian cancer	0.0137	0.0137	CcSEcCtD
Dimenhydrinate—Asthenia—Altretamine—ovarian cancer	0.0123	0.0123	CcSEcCtD
Dimenhydrinate—Haemolytic anaemia—Melphalan—ovarian cancer	0.0119	0.0119	CcSEcCtD
Dimenhydrinate—Neuritis—Paclitaxel—ovarian cancer	0.0117	0.0117	CcSEcCtD
Dimenhydrinate—Dizziness—Altretamine—ovarian cancer	0.0113	0.0113	CcSEcCtD
Dimenhydrinate—Vomiting—Altretamine—ovarian cancer	0.0109	0.0109	CcSEcCtD
Dimenhydrinate—Extrasystoles—Paclitaxel—ovarian cancer	0.0104	0.0104	CcSEcCtD
Dimenhydrinate—Nausea—Altretamine—ovarian cancer	0.0102	0.0102	CcSEcCtD
Dimenhydrinate—Neuritis—Docetaxel—ovarian cancer	0.00991	0.00991	CcSEcCtD
Dimenhydrinate—Chest discomfort—Paclitaxel—ovarian cancer	0.00987	0.00987	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Chlorambucil—ovarian cancer	0.00935	0.00935	CcSEcCtD
Dimenhydrinate—Wheezing—Paclitaxel—ovarian cancer	0.00848	0.00848	CcSEcCtD
Dimenhydrinate—Chest discomfort—Docetaxel—ovarian cancer	0.00836	0.00836	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Topotecan—ovarian cancer	0.00832	0.00832	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Melphalan—ovarian cancer	0.00815	0.00815	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Vinorelbine—ovarian cancer	0.00712	0.00712	CcSEcCtD
Dimenhydrinate—Tremor—Chlorambucil—ovarian cancer	0.00698	0.00698	CcSEcCtD
Dimenhydrinate—Nasal congestion—Paclitaxel—ovarian cancer	0.00696	0.00696	CcSEcCtD
Dimenhydrinate—Agitation—Chlorambucil—ovarian cancer	0.00685	0.00685	CcSEcCtD
Dimenhydrinate—Chills—Topotecan—ovarian cancer	0.00684	0.00684	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Vinorelbine—ovarian cancer	0.00678	0.00678	CcSEcCtD
Dimenhydrinate—Neuritis—Epirubicin—ovarian cancer	0.00669	0.00669	CcSEcCtD
Dimenhydrinate—Convulsion—Chlorambucil—ovarian cancer	0.00646	0.00646	CcSEcCtD
Dimenhydrinate—Neuritis—Doxorubicin—ovarian cancer	0.00619	0.00619	CcSEcCtD
Dimenhydrinate—Confusional state—Chlorambucil—ovarian cancer	0.00613	0.00613	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Chlorambucil—ovarian cancer	0.00596	0.00596	CcSEcCtD
Dimenhydrinate—Anorexia—Chlorambucil—ovarian cancer	0.0058	0.0058	CcSEcCtD
Dimenhydrinate—Convulsion—Melphalan—ovarian cancer	0.00563	0.00563	CcSEcCtD
Dimenhydrinate—Dyspepsia—Chlorambucil—ovarian cancer	0.00535	0.00535	CcSEcCtD
Dimenhydrinate—Sweating increased—Paclitaxel—ovarian cancer	0.00534	0.00534	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Topotecan—ovarian cancer	0.0053	0.0053	CcSEcCtD
Dimenhydrinate—Decreased appetite—Chlorambucil—ovarian cancer	0.00529	0.00529	CcSEcCtD
Dimenhydrinate—Fatigue—Chlorambucil—ovarian cancer	0.00524	0.00524	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Topotecan—ovarian cancer	0.00523	0.00523	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Melphalan—ovarian cancer	0.00519	0.00519	CcSEcCtD
Dimenhydrinate—Tachycardia—Melphalan—ovarian cancer	0.00517	0.00517	CcSEcCtD
Dimenhydrinate—Anorexia—Topotecan—ovarian cancer	0.00516	0.00516	CcSEcCtD
Dimenhydrinate—Dysuria—Paclitaxel—ovarian cancer	0.00512	0.00512	CcSEcCtD
Dimenhydrinate—Vertigo—Vinorelbine—ovarian cancer	0.0051	0.0051	CcSEcCtD
Dimenhydrinate—Pollakiuria—Paclitaxel—ovarian cancer	0.00506	0.00506	CcSEcCtD
Dimenhydrinate—Anorexia—Melphalan—ovarian cancer	0.00505	0.00505	CcSEcCtD
Dimenhydrinate—Palpitations—Vinorelbine—ovarian cancer	0.00502	0.00502	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Chlorambucil—ovarian cancer	0.00501	0.00501	CcSEcCtD
Dimenhydrinate—Photosensitivity reaction—Paclitaxel—ovarian cancer	0.005	0.005	CcSEcCtD
Dimenhydrinate—Hypotension—Melphalan—ovarian cancer	0.00495	0.00495	CcSEcCtD
Dimenhydrinate—Paraesthesia—Topotecan—ovarian cancer	0.00486	0.00486	CcSEcCtD
Dimenhydrinate—Urticaria—Chlorambucil—ovarian cancer	0.00483	0.00483	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Paclitaxel—ovarian cancer	0.00479	0.00479	CcSEcCtD
Dimenhydrinate—Dyspepsia—Topotecan—ovarian cancer	0.00477	0.00477	CcSEcCtD
Dimenhydrinate—Paraesthesia—Melphalan—ovarian cancer	0.00476	0.00476	CcSEcCtD
Dimenhydrinate—Decreased appetite—Topotecan—ovarian cancer	0.00471	0.00471	CcSEcCtD
Dimenhydrinate—Fatigue—Topotecan—ovarian cancer	0.00467	0.00467	CcSEcCtD
Dimenhydrinate—Dyspepsia—Melphalan—ovarian cancer	0.00467	0.00467	CcSEcCtD
Dimenhydrinate—Constipation—Topotecan—ovarian cancer	0.00463	0.00463	CcSEcCtD
Dimenhydrinate—Decreased appetite—Melphalan—ovarian cancer	0.00461	0.00461	CcSEcCtD
Dimenhydrinate—Fatigue—Melphalan—ovarian cancer	0.00457	0.00457	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Vinorelbine—ovarian cancer	0.00453	0.00453	CcSEcCtD
Dimenhydrinate—Tachycardia—Vinorelbine—ovarian cancer	0.00452	0.00452	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Topotecan—ovarian cancer	0.00446	0.00446	CcSEcCtD
Dimenhydrinate—Anorexia—Vinorelbine—ovarian cancer	0.00442	0.00442	CcSEcCtD
Dimenhydrinate—Asthenia—Chlorambucil—ovarian cancer	0.00436	0.00436	CcSEcCtD
Dimenhydrinate—Hypotension—Vinorelbine—ovarian cancer	0.00433	0.00433	CcSEcCtD
Dimenhydrinate—Urticaria—Topotecan—ovarian cancer	0.0043	0.0043	CcSEcCtD
Dimenhydrinate—Urticaria—Melphalan—ovarian cancer	0.00421	0.00421	CcSEcCtD
Dimenhydrinate—Diarrhoea—Chlorambucil—ovarian cancer	0.00416	0.00416	CcSEcCtD
Dimenhydrinate—Paraesthesia—Vinorelbine—ovarian cancer	0.00416	0.00416	CcSEcCtD
Dimenhydrinate—Photosensitivity—Epirubicin—ovarian cancer	0.00413	0.00413	CcSEcCtD
Dimenhydrinate—Tinnitus—Paclitaxel—ovarian cancer	0.00409	0.00409	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Docetaxel—ovarian cancer	0.00406	0.00406	CcSEcCtD
Dimenhydrinate—Decreased appetite—Vinorelbine—ovarian cancer	0.00403	0.00403	CcSEcCtD
Dimenhydrinate—Fatigue—Vinorelbine—ovarian cancer	0.00399	0.00399	CcSEcCtD
Dimenhydrinate—Constipation—Vinorelbine—ovarian cancer	0.00396	0.00396	CcSEcCtD
Dimenhydrinate—Chills—Paclitaxel—ovarian cancer	0.00393	0.00393	CcSEcCtD
Dimenhydrinate—Asthenia—Topotecan—ovarian cancer	0.00388	0.00388	CcSEcCtD
Dimenhydrinate—Vomiting—Chlorambucil—ovarian cancer	0.00387	0.00387	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Docetaxel—ovarian cancer	0.00386	0.00386	CcSEcCtD
Dimenhydrinate—Photosensitivity—Doxorubicin—ovarian cancer	0.00382	0.00382	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Vinorelbine—ovarian cancer	0.00382	0.00382	CcSEcCtD
Dimenhydrinate—Asthenia—Melphalan—ovarian cancer	0.0038	0.0038	CcSEcCtD
Dimenhydrinate—Tension—Paclitaxel—ovarian cancer	0.00375	0.00375	CcSEcCtD
Dimenhydrinate—Nervousness—Paclitaxel—ovarian cancer	0.00371	0.00371	CcSEcCtD
Dimenhydrinate—Diarrhoea—Topotecan—ovarian cancer	0.0037	0.0037	CcSEcCtD
Dimenhydrinate—Urticaria—Vinorelbine—ovarian cancer	0.00368	0.00368	CcSEcCtD
Dimenhydrinate—Diarrhoea—Melphalan—ovarian cancer	0.00363	0.00363	CcSEcCtD
Dimenhydrinate—Diplopia—Epirubicin—ovarian cancer	0.00362	0.00362	CcSEcCtD
Dimenhydrinate—Nausea—Chlorambucil—ovarian cancer	0.00361	0.00361	CcSEcCtD
Dimenhydrinate—Vision blurred—Paclitaxel—ovarian cancer	0.0036	0.0036	CcSEcCtD
Dimenhydrinate—Dizziness—Topotecan—ovarian cancer	0.00358	0.00358	CcSEcCtD
Dimenhydrinate—Tremor—Paclitaxel—ovarian cancer	0.00358	0.00358	CcSEcCtD
Dimenhydrinate—Agitation—Paclitaxel—ovarian cancer	0.00351	0.00351	CcSEcCtD
Dimenhydrinate—Vomiting—Topotecan—ovarian cancer	0.00344	0.00344	CcSEcCtD
Dimenhydrinate—Vertigo—Paclitaxel—ovarian cancer	0.00343	0.00343	CcSEcCtD
Dimenhydrinate—Rash—Topotecan—ovarian cancer	0.00341	0.00341	CcSEcCtD
Dimenhydrinate—Dermatitis—Topotecan—ovarian cancer	0.00341	0.00341	CcSEcCtD
Dimenhydrinate—Headache—Topotecan—ovarian cancer	0.00339	0.00339	CcSEcCtD
Dimenhydrinate—Palpitations—Paclitaxel—ovarian cancer	0.00337	0.00337	CcSEcCtD
Dimenhydrinate—Vomiting—Melphalan—ovarian cancer	0.00337	0.00337	CcSEcCtD
Dimenhydrinate—Diplopia—Doxorubicin—ovarian cancer	0.00335	0.00335	CcSEcCtD
Dimenhydrinate—Rash—Melphalan—ovarian cancer	0.00334	0.00334	CcSEcCtD
Dimenhydrinate—Dermatitis—Melphalan—ovarian cancer	0.00334	0.00334	CcSEcCtD
Dimenhydrinate—Chills—Docetaxel—ovarian cancer	0.00333	0.00333	CcSEcCtD
Dimenhydrinate—Asthenia—Vinorelbine—ovarian cancer	0.00332	0.00332	CcSEcCtD
Dimenhydrinate—Convulsion—Paclitaxel—ovarian cancer	0.00331	0.00331	CcSEcCtD
Dimenhydrinate—Nausea—Topotecan—ovarian cancer	0.00322	0.00322	CcSEcCtD
Dimenhydrinate—Dry mouth—Paclitaxel—ovarian cancer	0.00318	0.00318	CcSEcCtD
Dimenhydrinate—Diarrhoea—Vinorelbine—ovarian cancer	0.00317	0.00317	CcSEcCtD
Dimenhydrinate—Nausea—Melphalan—ovarian cancer	0.00315	0.00315	CcSEcCtD
Dimenhydrinate—Confusional state—Paclitaxel—ovarian cancer	0.00314	0.00314	CcSEcCtD
Dimenhydrinate—Dizziness—Vinorelbine—ovarian cancer	0.00306	0.00306	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00305	0.00305	CcSEcCtD
Dimenhydrinate—Tachycardia—Paclitaxel—ovarian cancer	0.00304	0.00304	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00301	0.00301	CcSEcCtD
Dimenhydrinate—Anorexia—Paclitaxel—ovarian cancer	0.00297	0.00297	CcSEcCtD
Dimenhydrinate—Vomiting—Vinorelbine—ovarian cancer	0.00294	0.00294	CcSEcCtD
Dimenhydrinate—Dysuria—Epirubicin—ovarian cancer	0.00293	0.00293	CcSEcCtD
Dimenhydrinate—Rash—Vinorelbine—ovarian cancer	0.00292	0.00292	CcSEcCtD
Dimenhydrinate—Dermatitis—Vinorelbine—ovarian cancer	0.00292	0.00292	CcSEcCtD
Dimenhydrinate—Hypotension—Paclitaxel—ovarian cancer	0.00291	0.00291	CcSEcCtD
Dimenhydrinate—Headache—Vinorelbine—ovarian cancer	0.0029	0.0029	CcSEcCtD
Dimenhydrinate—Pollakiuria—Epirubicin—ovarian cancer	0.00289	0.00289	CcSEcCtD
Dimenhydrinate—Palpitations—Docetaxel—ovarian cancer	0.00286	0.00286	CcSEcCtD
Dimenhydrinate—Photosensitivity reaction—Epirubicin—ovarian cancer	0.00286	0.00286	CcSEcCtD
Dimenhydrinate—Insomnia—Paclitaxel—ovarian cancer	0.00282	0.00282	CcSEcCtD
Dimenhydrinate—Convulsion—Docetaxel—ovarian cancer	0.0028	0.0028	CcSEcCtD
Dimenhydrinate—Paraesthesia—Paclitaxel—ovarian cancer	0.0028	0.0028	CcSEcCtD
Dimenhydrinate—Drowsiness—Epirubicin—ovarian cancer	0.00279	0.00279	CcSEcCtD
Dimenhydrinate—Somnolence—Paclitaxel—ovarian cancer	0.00277	0.00277	CcSEcCtD
Dimenhydrinate—Nausea—Vinorelbine—ovarian cancer	0.00275	0.00275	CcSEcCtD
Dimenhydrinate—Dyspepsia—Paclitaxel—ovarian cancer	0.00274	0.00274	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Epirubicin—ovarian cancer	0.00274	0.00274	CcSEcCtD
Dimenhydrinate—Dysuria—Doxorubicin—ovarian cancer	0.00271	0.00271	CcSEcCtD
Dimenhydrinate—Decreased appetite—Paclitaxel—ovarian cancer	0.00271	0.00271	CcSEcCtD
Dimenhydrinate—Dry mouth—Docetaxel—ovarian cancer	0.00269	0.00269	CcSEcCtD
Dimenhydrinate—Fatigue—Paclitaxel—ovarian cancer	0.00269	0.00269	CcSEcCtD
Dimenhydrinate—Pollakiuria—Doxorubicin—ovarian cancer	0.00268	0.00268	CcSEcCtD
Dimenhydrinate—Constipation—Paclitaxel—ovarian cancer	0.00266	0.00266	CcSEcCtD
Dimenhydrinate—Confusional state—Docetaxel—ovarian cancer	0.00266	0.00266	CcSEcCtD
Dimenhydrinate—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.00265	0.00265	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Epirubicin—ovarian cancer	0.00261	0.00261	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Docetaxel—ovarian cancer	0.00259	0.00259	CcSEcCtD
Dimenhydrinate—Drowsiness—Doxorubicin—ovarian cancer	0.00258	0.00258	CcSEcCtD
Dimenhydrinate—Tachycardia—Docetaxel—ovarian cancer	0.00258	0.00258	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Paclitaxel—ovarian cancer	0.00257	0.00257	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.00253	0.00253	CcSEcCtD
Dimenhydrinate—Anorexia—Docetaxel—ovarian cancer	0.00252	0.00252	CcSEcCtD
Dimenhydrinate—Urticaria—Paclitaxel—ovarian cancer	0.00247	0.00247	CcSEcCtD
Dimenhydrinate—Hypotension—Docetaxel—ovarian cancer	0.00247	0.00247	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Doxorubicin—ovarian cancer	0.00241	0.00241	CcSEcCtD
Dimenhydrinate—Insomnia—Docetaxel—ovarian cancer	0.00239	0.00239	CcSEcCtD
Dimenhydrinate—Paraesthesia—Docetaxel—ovarian cancer	0.00237	0.00237	CcSEcCtD
Dimenhydrinate—Somnolence—Docetaxel—ovarian cancer	0.00235	0.00235	CcSEcCtD
Dimenhydrinate—Tinnitus—Epirubicin—ovarian cancer	0.00234	0.00234	CcSEcCtD
Dimenhydrinate—Dyspepsia—Docetaxel—ovarian cancer	0.00232	0.00232	CcSEcCtD
Dimenhydrinate—Decreased appetite—Docetaxel—ovarian cancer	0.0023	0.0023	CcSEcCtD
Dimenhydrinate—Fatigue—Docetaxel—ovarian cancer	0.00228	0.00228	CcSEcCtD
Dimenhydrinate—Constipation—Docetaxel—ovarian cancer	0.00226	0.00226	CcSEcCtD
Dimenhydrinate—Chills—Epirubicin—ovarian cancer	0.00225	0.00225	CcSEcCtD
Dimenhydrinate—Asthenia—Paclitaxel—ovarian cancer	0.00224	0.00224	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Docetaxel—ovarian cancer	0.00218	0.00218	CcSEcCtD
Dimenhydrinate—Tinnitus—Doxorubicin—ovarian cancer	0.00216	0.00216	CcSEcCtD
Dimenhydrinate—Tension—Epirubicin—ovarian cancer	0.00214	0.00214	CcSEcCtD
Dimenhydrinate—Diarrhoea—Paclitaxel—ovarian cancer	0.00213	0.00213	CcSEcCtD
Dimenhydrinate—Nervousness—Epirubicin—ovarian cancer	0.00212	0.00212	CcSEcCtD
Dimenhydrinate—Chills—Doxorubicin—ovarian cancer	0.00208	0.00208	CcSEcCtD
Dimenhydrinate—Dizziness—Paclitaxel—ovarian cancer	0.00206	0.00206	CcSEcCtD
Dimenhydrinate—Vision blurred—Epirubicin—ovarian cancer	0.00206	0.00206	CcSEcCtD
Dimenhydrinate—Agitation—Epirubicin—ovarian cancer	0.00201	0.00201	CcSEcCtD
Dimenhydrinate—Tension—Doxorubicin—ovarian cancer	0.00198	0.00198	CcSEcCtD
Dimenhydrinate—Vomiting—Paclitaxel—ovarian cancer	0.00198	0.00198	CcSEcCtD
Dimenhydrinate—Rash—Paclitaxel—ovarian cancer	0.00196	0.00196	CcSEcCtD
Dimenhydrinate—Dermatitis—Paclitaxel—ovarian cancer	0.00196	0.00196	CcSEcCtD
Dimenhydrinate—Nervousness—Doxorubicin—ovarian cancer	0.00196	0.00196	CcSEcCtD
Dimenhydrinate—Vertigo—Epirubicin—ovarian cancer	0.00196	0.00196	CcSEcCtD
Dimenhydrinate—Headache—Paclitaxel—ovarian cancer	0.00195	0.00195	CcSEcCtD
Dimenhydrinate—Palpitations—Epirubicin—ovarian cancer	0.00193	0.00193	CcSEcCtD
Dimenhydrinate—Vision blurred—Doxorubicin—ovarian cancer	0.0019	0.0019	CcSEcCtD
Dimenhydrinate—Asthenia—Docetaxel—ovarian cancer	0.00189	0.00189	CcSEcCtD
Dimenhydrinate—Convulsion—Epirubicin—ovarian cancer	0.00189	0.00189	CcSEcCtD
Dimenhydrinate—Agitation—Doxorubicin—ovarian cancer	0.00186	0.00186	CcSEcCtD
Dimenhydrinate—Nausea—Paclitaxel—ovarian cancer	0.00185	0.00185	CcSEcCtD
Dimenhydrinate—Dry mouth—Epirubicin—ovarian cancer	0.00182	0.00182	CcSEcCtD
Dimenhydrinate—Vertigo—Doxorubicin—ovarian cancer	0.00181	0.00181	CcSEcCtD
Dimenhydrinate—Diarrhoea—Docetaxel—ovarian cancer	0.00181	0.00181	CcSEcCtD
Dimenhydrinate—Confusional state—Epirubicin—ovarian cancer	0.0018	0.0018	CcSEcCtD
Dimenhydrinate—Palpitations—Doxorubicin—ovarian cancer	0.00178	0.00178	CcSEcCtD
Dimenhydrinate—Convulsion—Doxorubicin—ovarian cancer	0.00175	0.00175	CcSEcCtD
Dimenhydrinate—Dizziness—Docetaxel—ovarian cancer	0.00175	0.00175	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Epirubicin—ovarian cancer	0.00174	0.00174	CcSEcCtD
Dimenhydrinate—Tachycardia—Epirubicin—ovarian cancer	0.00174	0.00174	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Epirubicin—ovarian cancer	0.00172	0.00172	CcSEcCtD
Dimenhydrinate—Anorexia—Epirubicin—ovarian cancer	0.0017	0.0017	CcSEcCtD
Dimenhydrinate—Dry mouth—Doxorubicin—ovarian cancer	0.00168	0.00168	CcSEcCtD
Dimenhydrinate—Vomiting—Docetaxel—ovarian cancer	0.00168	0.00168	CcSEcCtD
Dimenhydrinate—Rash—Docetaxel—ovarian cancer	0.00166	0.00166	CcSEcCtD
Dimenhydrinate—Hypotension—Epirubicin—ovarian cancer	0.00166	0.00166	CcSEcCtD
Dimenhydrinate—Dermatitis—Docetaxel—ovarian cancer	0.00166	0.00166	CcSEcCtD
Dimenhydrinate—Confusional state—Doxorubicin—ovarian cancer	0.00166	0.00166	CcSEcCtD
Dimenhydrinate—Headache—Docetaxel—ovarian cancer	0.00165	0.00165	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Doxorubicin—ovarian cancer	0.00161	0.00161	CcSEcCtD
Dimenhydrinate—Insomnia—Epirubicin—ovarian cancer	0.00161	0.00161	CcSEcCtD
Dimenhydrinate—Tachycardia—Doxorubicin—ovarian cancer	0.00161	0.00161	CcSEcCtD
Dimenhydrinate—Paraesthesia—Epirubicin—ovarian cancer	0.0016	0.0016	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Doxorubicin—ovarian cancer	0.00159	0.00159	CcSEcCtD
Dimenhydrinate—Somnolence—Epirubicin—ovarian cancer	0.00158	0.00158	CcSEcCtD
Dimenhydrinate—Anorexia—Doxorubicin—ovarian cancer	0.00157	0.00157	CcSEcCtD
Dimenhydrinate—Nausea—Docetaxel—ovarian cancer	0.00157	0.00157	CcSEcCtD
Dimenhydrinate—Dyspepsia—Epirubicin—ovarian cancer	0.00157	0.00157	CcSEcCtD
Dimenhydrinate—Decreased appetite—Epirubicin—ovarian cancer	0.00155	0.00155	CcSEcCtD
Dimenhydrinate—Hypotension—Doxorubicin—ovarian cancer	0.00154	0.00154	CcSEcCtD
Dimenhydrinate—Fatigue—Epirubicin—ovarian cancer	0.00154	0.00154	CcSEcCtD
Dimenhydrinate—Constipation—Epirubicin—ovarian cancer	0.00152	0.00152	CcSEcCtD
Dimenhydrinate—Insomnia—Doxorubicin—ovarian cancer	0.00149	0.00149	CcSEcCtD
Dimenhydrinate—Paraesthesia—Doxorubicin—ovarian cancer	0.00148	0.00148	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Epirubicin—ovarian cancer	0.00147	0.00147	CcSEcCtD
Dimenhydrinate—Somnolence—Doxorubicin—ovarian cancer	0.00147	0.00147	CcSEcCtD
Dimenhydrinate—Dyspepsia—Doxorubicin—ovarian cancer	0.00145	0.00145	CcSEcCtD
Dimenhydrinate—Decreased appetite—Doxorubicin—ovarian cancer	0.00143	0.00143	CcSEcCtD
Dimenhydrinate—Fatigue—Doxorubicin—ovarian cancer	0.00142	0.00142	CcSEcCtD
Dimenhydrinate—Urticaria—Epirubicin—ovarian cancer	0.00141	0.00141	CcSEcCtD
Dimenhydrinate—Constipation—Doxorubicin—ovarian cancer	0.00141	0.00141	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Doxorubicin—ovarian cancer	0.00136	0.00136	CcSEcCtD
Dimenhydrinate—Urticaria—Doxorubicin—ovarian cancer	0.00131	0.00131	CcSEcCtD
Dimenhydrinate—Asthenia—Epirubicin—ovarian cancer	0.00128	0.00128	CcSEcCtD
Dimenhydrinate—Diarrhoea—Epirubicin—ovarian cancer	0.00122	0.00122	CcSEcCtD
Dimenhydrinate—Asthenia—Doxorubicin—ovarian cancer	0.00118	0.00118	CcSEcCtD
Dimenhydrinate—Dizziness—Epirubicin—ovarian cancer	0.00118	0.00118	CcSEcCtD
Dimenhydrinate—Vomiting—Epirubicin—ovarian cancer	0.00113	0.00113	CcSEcCtD
Dimenhydrinate—Diarrhoea—Doxorubicin—ovarian cancer	0.00113	0.00113	CcSEcCtD
Dimenhydrinate—Rash—Epirubicin—ovarian cancer	0.00112	0.00112	CcSEcCtD
Dimenhydrinate—Dermatitis—Epirubicin—ovarian cancer	0.00112	0.00112	CcSEcCtD
Dimenhydrinate—Headache—Epirubicin—ovarian cancer	0.00112	0.00112	CcSEcCtD
Dimenhydrinate—Dizziness—Doxorubicin—ovarian cancer	0.00109	0.00109	CcSEcCtD
Dimenhydrinate—Nausea—Epirubicin—ovarian cancer	0.00106	0.00106	CcSEcCtD
Dimenhydrinate—Vomiting—Doxorubicin—ovarian cancer	0.00105	0.00105	CcSEcCtD
Dimenhydrinate—Rash—Doxorubicin—ovarian cancer	0.00104	0.00104	CcSEcCtD
Dimenhydrinate—Dermatitis—Doxorubicin—ovarian cancer	0.00104	0.00104	CcSEcCtD
Dimenhydrinate—Headache—Doxorubicin—ovarian cancer	0.00103	0.00103	CcSEcCtD
Dimenhydrinate—Nausea—Doxorubicin—ovarian cancer	0.000979	0.000979	CcSEcCtD
